Skip to main content

August has been a very exciting month for CNX; we have welcomed four new faces to the team!

Our recent product acquisitions mean it’s vital to have a talented and dynamic team in in place as we expand our portfolio and work towards our goal of becoming a leading provider of critical medicines.

Joining our Corporate Development team we have Miguel Sabariego who will be developing and maintaining our robust product pipelines, and Natalia Isakova who will be supporting our deals and transactions. Both Miguel and Natalie bring a wealth of experience to the team and will help support CNX with our acquisition activities across both business development and M&A.

We also have also been joined by Chad Reid as Technical Project Manager. Chad brings significant manufacturing experience to CNX and he will be focussing on technical transfer activities and manufacturing processes across our portfolio.

Finally, we have also welcomed our second Summer Intern for 2023, Esha Dhorajiwala! Esha is currently studying law at Keele University and will be working exclusively within our Legal function during her internship, allowing her to gain hands-on experience and insights into working within a growing and fast paced pharmaceutical company.

It’s fantastic to have a growing team of talented people who bring such a wealth of experience in their respective fields.